Evidence map›Paper›PMID 21854643›Full record

Trial reportBMC geriatrics2011

[Cost] effectiveness of withdrawal of fall-risk increasing drugs versus conservative treatment in older fallers: design of a multicenter randomized controlled trial (IMPROveFALL-study).

Klaas A Hartholt, Nicole D A Boyé, Nathalie Van der Velde, Esther M M Van Lieshout, Suzanne Polinder, Oscar J De Vries, Albert J H Kerver, Gijsbertus Ziere, Milko M M Bruijninckx, Mark R De Vries and 6 more

Abstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC geriatrics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Interventions for preventing falls in older people living in the community.The Cochrane database of systematic reviews · 2012
    Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Klaas A HartholtDepartment of Internal Medicine - Section Geriatric Medicine, Erasmus MC, University Medical Rotterdam, P,O, Box 2040, 3000 CA Rotterdam, The Netherlands.
Nicole D A Boyé
Nathalie Van der Velde
Esther M M Van Lieshout
Suzanne Polinder
Oscar J De Vries
Albert J H Kerver
Gijsbertus Ziere
Milko M M Bruijninckx
Mark R De Vries
Francesco U S Mattace-Raso
André G Uitterlinden
Ed F Van Beeck
Paul Lips
Peter Patka
Tischa J M Van der Cammen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFall incidents represent an increasing public health problem in aging societies worldwide. A major risk factor for falls is the use of fall-risk increasing drugs. The primary aim of the study is to compare the effect of a structured medication assessment including the withdrawal of fall-risk increasing drugs on the number of new falls versus 'care as usual' in older adults presenting at the Emergency Department after a fall. METHODS/

designA prospective, multi-center, randomized controlled trial will be conducted in hospitals in the Netherlands. Persons aged ≥65 years who visit the Emergency Department due to a fall are invited to participate in this trial. All patients receive a full geriatric assessment at the research outpatient clinic. Patients are randomized between a structured medication assessment including withdrawal of fall-risk increasing drugs and 'care as usual'. A 3-monthly falls calendar is used for assessing the number of falls, fallers and associated injuries over a one-year follow-up period. Measurements will be at three, six, nine, and twelve months and include functional outcome, healthcare consumption, socio-demographic characteristics, and clinical information. After twelve months a second visit to the research outpatient clinic will be performed, and adherence to the new medication regimen in the intervention group will be measured. The primary outcome will be the incidence of new falls. Secondary outcome measurements are possible health effects of medication withdrawal, health-related quality of life (Short Form-12 and EuroQol-5D), costs, and cost-effectiveness of the intervention. Data will be analyzed using an intention-to-treat analysis. DISCUSSION: The successful completion of this trial will provide evidence on the effectiveness of withdrawal of fall-risk increasing drugs in older patients as a method for falls reduction.

trial registrationThe trial is registered in the Netherlands Trial Register (NTR1593).

Indexed as

Drug-Related Side Effects and Adverse ReactionsAccidental FallsAgedAged, 80 and overCost-Benefit AnalysisFemaleFollow-Up StudiesHumansMalePharmaceutical PreparationsProspective StudiesRisk FactorsTreatment OutcomePharmaceutical Preparations

Identifiers

PMID21854643
PMCPMC3176146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.